gemcitabine has been researched along with Adenopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Furuya, N; Hamada, T; Ito, T; Kato, N; Kido, M; Kohno, H; Kouno, H; Kuraoka, K; Kusunoki, R; Kuwai, T; Mizumoto, T; Sugata, S; Tamaru, Y; Yamaguchi, A | 1 |
| Drevinskaite, M; Kevlicius, L; Mickys, U; Patasius, A; Smailyte, G | 1 |
| Higuchi, Y; Kato, H; Kinoshita, T; Nakamura, S; Saito, T; Taji, H; Yamamoto, H; Yamamoto, K; Yatabe, Y | 1 |
2 review(s) available for gemcitabine and Adenopathy
| Article | Year |
|---|---|
Metastatic pancreatic ductal adenocarcinoma followed by a fatal diffuse large B-cell lymphoma: A rare case report and literature review.
Topics: Adenocarcinoma; Aged; Carcinoma, Pancreatic Ductal; Female; Gemcitabine; Humans; Lymphadenopathy; Lymphoma, Large B-Cell, Diffuse; Pancreatic Neoplasms | 2023 |
Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature.
Topics: Aged; Antineoplastic Agents; Biopsy; Cisplatin; Deoxycytidine; Disease Progression; Fatal Outcome; Gemcitabine; Humans; Lung Neoplasms; Lymphadenopathy; Male; Mesothelioma; Mesothelioma, Malignant; Orchiectomy; Pemetrexed; Prognosis; Testicular Hydrocele; Testicular Neoplasms | 2020 |
1 other study(ies) available for gemcitabine and Adenopathy
| Article | Year |
|---|---|
Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Humans; Lymphadenopathy; Lymphatic Metastasis; Lymphoma, T-Cell; Receptors, CCR4; Salvage Therapy; Tomography, X-Ray Computed | 2017 |